Affective disorders in advanced cancer.
Depression is a common complication of advanced cancer. Methods of accurate assessment and recognition are available. Risk factors for the development of depression have been identified. Pharmacologic and nonpharmacologic treatments for depression are often effective even in patients with advanced cancer.
Potash
Mordecai
M
Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 1242 Second Avenue, New York, NY 10021, USA.
Breitbart
William
W
D000203:Activities of Daily Living; D000928:Antidepressive Agents / Q000627:therapeutic use; D015415:Biomarkers; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000523:psychology / Q000628:therapy*; D006801:Humans; D007406:Interview, Psychological; D009367:Neoplasm Staging; D009369:Neoplasms / Q000150:complications* / Q000523:psychology; D010166:Palliative Care / Q000379:methods* / Q000523:psychology; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D011613:Psychotherapy; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000928:Antidepressive Agents; D015415:Biomarkers; D000697:Central Nervous System Stimulants